EN | TR
E-ISSN: 3061-9947
The Relationship between AB0 Blood Group and Malignant Soft - Tissue Sarcomas
PDF
Cite
Share
Request
Original Article
VOLUME: 53 ISSUE: 2
P: 274-280
2020

The Relationship between AB0 Blood Group and Malignant Soft - Tissue Sarcomas

Acta Haematol Oncol Turc 2020;53(2):274-280
DOI: 10.5505/aot.2020.62347
Aliekber Yapar 1
Fevzi Coşkun Sökmen 1
1. Ankara Oncology Training and Research Hospital
2.
No information available.
No information available
Received Date: 2020-03-27T13:03:22
Accepted Date: 2020-09-04T11:00:35
PDF
Cite
Share
Request

Abstract

INTRODUCTION

The aim of this study is to evaluate the relationship between malignant soft-tissue sarcomas and AB0 blood groups.

METHODS

The blood groups, tumor types, age and gender information of 206 patients (case group) operated for malignant soft-tissue sarcoma between 2010-2018 were evaluated retrospectively. The control group consisted of 249 (54.7%) healthy volunteers who were similar in age and gender to the case group that applied to blood center of our hospital.

RESULTS

The average age of the case group was 49.5 ± 17.3; the control group is 49.5 ± 19.9 years. When the distribution of AB0 blood group characteristics in the case group was analyzed, patients with 42.7% A blood group, 30.1% 0 blood group, 19.9% B blood group and 7.3% AB blood group were observed. It was found that the distribution of AB0 blood group showed a similar distribution in the control group as well. Accordingly, A blood group 44.2%, 0 blood group 28.5%, B blood group 19.3% and AB blood group 8%. The AB0 blood group distributions of the case and control groups were found to be statistically similar. In the case group, 89.8% of the patients were Rh (+) and in the control group, 86.7% of the patients were Rh (+), and there was no statistically significant difference between the groups.

DISCUSSION AND CONCLUSION

In conclusion, in this study, no significant relationship was found between malignant soft tissue sarcomas and AB0 and Rh groups. In order to understand whether AB0 blood groups guide the differential diagnosis of malignant soft tissue sarcomas, larger sample studies are needed, especially considering the number of patients in tumor subgroups.